{"gene":"GABRA1","run_date":"2026-04-28T17:46:04","timeline":{"discoveries":[{"year":2002,"finding":"The Ala322Asp missense mutation in GABRA1 (encoding the GABA-A receptor α1 subunit) causes reduced amplitude of GABA-activated currents in vitro, demonstrating loss-of-function of this inhibitory ligand-gated ion channel and establishing that seizures in juvenile myoclonic epilepsy result from reduced inhibitory neurotransmission.","method":"In vitro electrophysiology of mutant GABA-A receptors expressing the Ala322Asp variant","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional assay with direct current measurement, foundational paper with 459 citations","pmids":["11992121"],"is_preprint":false},{"year":2009,"finding":"The GABRA1 PTC mutation 975delC (S326fs328X) triggers nonsense-mediated mRNA decay (NMD) that substantially reduces mutant mRNA levels; residual mutant protein undergoes endoplasmic reticulum-associated degradation (ERAD) with enhanced association with molecular chaperones, demonstrating that both NMD and ERAD contribute to loss of α1 subunit and epileptogenesis.","method":"Minigene NMD assay, ribosome inhibition, siRNA knockdown of hUPF-1, pulse-chase protein stability assay, co-immunoprecipitation with chaperones in neurons and non-neuronal cells","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods (NMD reporter, siRNA rescue, ERAD assay, chaperone co-IP) in a single rigorous study","pmids":["19261879"],"is_preprint":false},{"year":2016,"finding":"Functional analysis of selected GABRA1 mutations using the Xenopus laevis oocyte expression system revealed loss of function for all four tested mutations, without a clear genotype-phenotype correlation, confirming that loss-of-function is the primary mechanism across the phenotypic spectrum from mild epilepsy to severe epileptic encephalopathy.","method":"Two-electrode voltage clamp electrophysiology in Xenopus laevis oocytes expressing mutant GABA-A receptors","journal":"Neurology","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro electrophysiology in multiple mutations, replicated across international cohort","pmids":["27521439"],"is_preprint":false},{"year":2019,"finding":"Multiple de novo GABRA1 mutations associated with early-onset epileptic encephalopathy (P260S, L296S, W315L, R112Q, N115D) cause reduced cell-surface and total GABA-A receptor expression, altered endoplasmic reticulum processing, impaired synaptic clustering, reduced GABA-A receptor function, and decreased GABA binding potency when expressed in neuronal and non-neuronal cells.","method":"Whole-cell patch-clamp electrophysiology, surface biotinylation, confocal immunofluorescence for receptor clustering, ER processing assays in HEK293 cells and neurons","journal":"Brain : a journal of neurology","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (electrophysiology, surface expression, trafficking, clustering) in a single study","pmids":["31056671"],"is_preprint":false},{"year":2019,"finding":"The GABRA1 R214C variant reduces whole-cell GABA-evoked currents by decreasing single-channel open time and reducing both surface and total GABA-A receptor expression levels; verapamil treatment fully restores receptor function primarily by increasing channel open time, while diazepam and insulin only partially restore currents.","method":"Whole-cell, outside-out macro-patch, and cell-attached single-channel patch-clamp recordings; surface biotinylation assay; western blotting in HEK293 cells","journal":"Molecular brain","confidence":"High","confidence_rationale":"Tier 1 — single-channel recordings plus surface expression quantification with pharmacological rescue, multiple methods","pmids":["31707987"],"is_preprint":false},{"year":2020,"finding":"The de novo GABRA1 variant p.(Ala332Val) in TM3 produces unchanged protein levels and normal cell-surface trafficking but causes a significant left shift in apparent GABA potency (increased sensitivity) and altered desensitization kinetics, as well as a left shift in apparent diazepam potency, representing a gain-of-sensitivity rather than typical loss-of-function.","method":"Two-electrode voltage clamp electrophysiology, radioligand displacement assays, surface protein quantification","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 — in vitro electrophysiology plus radioligand binding with multiple functional readouts","pmids":["32047208"],"is_preprint":false},{"year":2021,"finding":"GABRA1 mutations in Dravet syndrome (L215P, R214C, V287I, R214H) cause defects primarily in receptor gating rather than trafficking, distinguishing α1 subunit variants from γ2 subunit variants (which show mainly trafficking defects), and demonstrating that α1 and β2 subunit variants are less tolerated and express well but are functionally deficient.","method":"Whole-cell patch-clamp electrophysiology, surface biotinylation, total protein quantification in HEK293 cells","journal":"Brain communications","confidence":"High","confidence_rationale":"Tier 1–2 — electrophysiology and trafficking assays across multiple variants with comparative analysis","pmids":["34095830"],"is_preprint":false},{"year":2022,"finding":"The GABRA1 T292S variant significantly increases GABA-evoked whole-cell currents (left-shifted dose-response, increased single-channel open time and open probability), while the T292I variant at the same residue markedly reduces GABA-evoked currents (right-shifted dose-response, decreased maximum response, reduced open time), establishing T292 as a critical residue controlling GABA-A receptor channel gating with bidirectional effects.","method":"Whole-cell and single-channel patch-clamp recordings in HEK293 cells expressing recombinant GABA-A receptors","journal":"International journal of molecular sciences","confidence":"High","confidence_rationale":"Tier 1 — single-channel recordings plus dose-response analysis for two variants at same residue, mechanistically rigorous","pmids":["35269865"],"is_preprint":false},{"year":2017,"finding":"Ethanol exposure reduces GABRA1 (α1 subunit) expression in cultured cortical neurons through class I HDAC-mediated histone deacetylation at the Gabra1 promoter; pharmacological inhibition or siRNA knockdown of HDAC1-3 prevents ethanol-induced reduction, and targeted histone acetylation using CRISPR dCas9-P300 at the Gabra1 promoter prevents the decrease in expression.","method":"CRISPR dCas9-P300 epigenome editing, HDAC inhibitors, siRNA knockdown, ChIP for histone acetylation marks, qPCR and western blot in cortical neurons","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal approaches including targeted epigenome editing with functional readout","pmids":["28798030"],"is_preprint":false},{"year":2025,"finding":"Four clinical GABRA1 frameshift variants (K401fs, S326fs, V290fs, F272fs) that truncate one to three transmembrane helices all show significantly reduced trafficking to the cell surface resulting in non-functional ion channels; variants exhibit ER retention and activate the unfolded protein response (UPR) to varying extents depending on the specific transmembrane domain deletions.","method":"Surface biotinylation, immunofluorescence for ER markers, UPR reporter assays, patch-clamp electrophysiology in HEK293T cells","journal":"bioRxiv : the preprint server for biology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in single preprint study not yet peer-reviewed","pmids":["39651292"],"is_preprint":true},{"year":2020,"finding":"Loss of gabra1 in zebrafish (morpholino knockdown) results in hypomotility and altered expression of other GABA-A receptor subunits; expression of wild-type human GABRA1 partially rescues the hypomotility phenotype, while the pathogenic c.875C>T variant fails to rescue, establishing loss-of-function as the disease mechanism.","method":"Zebrafish morpholino knockdown, behavioral analysis, rescue with wild-type versus mutant human GABRA1 mRNA","journal":"Biology open","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with rescue experiment, but morpholino-based knockdown has limitations","pmids":["32205311"],"is_preprint":false},{"year":2016,"finding":"In chronic heart failure rats, JNK activation downstream of prostaglandin E2/EP3 receptor signaling reduces GABRA1 (GABA-A receptor α1 subunit) expression in the paraventricular nucleus; JNK inhibitor SP600125 normalizes both sympathoexcitation and GABRA1 expression, placing GABRA1 downstream of the PGE2-PTGER3-JNK signaling axis.","method":"Pharmacological inhibition (SP600125 JNK inhibitor), western blot, qPCR, renal sympathetic nerve discharge measurement in rat CHF model","journal":"Acta physiologica","confidence":"Medium","confidence_rationale":"Tier 2 — epistasis via pharmacological inhibition with in vivo functional readout","pmids":["27439062"],"is_preprint":false},{"year":2021,"finding":"miR-139-5p directly targets GABRA1 mRNA, and overexpression of miR-139-5p inhibits glioma cell proliferation, migration, and invasion; upregulation of GABRA1 reverses these inhibitory effects, establishing a miR-139-5p/GABRA1 regulatory axis in glioma.","method":"Rescue experiments, cell proliferation/migration/invasion assays, luciferase reporter (implied), western blot in glioma cell lines","journal":"Journal of translational medicine","confidence":"Medium","confidence_rationale":"Tier 3 — rescue experiments in cancer cell lines establish target relationship but mechanism is indirect","pmids":["34001135"],"is_preprint":false},{"year":2021,"finding":"miR-129-2-3p directly targets GABRA1 3'UTR as validated by luciferase reporter assay; in a rat kainic acid seizure model, miR-129-2-3p is upregulated while GABRA1 is downregulated, and in vivo knockdown of miR-129-2-3p alleviates seizure-like EEG findings through upregulation of GABRA1.","method":"Luciferase reporter assay, qPCR, western blot, EEG recording, in vivo antagomir injection in rat KA seizure model","journal":"Brain and behavior","confidence":"Medium","confidence_rationale":"Tier 2–3 — luciferase validation of direct targeting plus in vivo functional rescue","pmids":["34029007"],"is_preprint":false},{"year":2024,"finding":"Loss-of-function of zebrafish gabra1 (sa43718 nonsense allele) results in light-induced hypermotility, decreased mRNA expression of other GABA-A receptor α subunits (gabra2, gabra3, gabra5), and abnormal expression of proteins regulating synaptic vesicle fusion, vesicle transport, synapse development, and mitochondrial complexes, as identified by proteomics.","method":"Germline mutant zebrafish behavioral analysis, qPCR, quantitative proteomics","journal":"Differentiation; research in biological diversity","confidence":"Medium","confidence_rationale":"Tier 2 — germline loss-of-function with proteomics and behavioral phenotyping in vertebrate model","pmids":["38908344"],"is_preprint":false},{"year":2023,"finding":"miR-181a-5p directly targets GABRA1 in vivo and in vitro; rhynchophylline reverses methamphetamine-induced conditioned place preference by suppressing miR-181a-5p, thereby restoring GABRA1 expression, establishing the miR-181a-5p/GABRA1 axis in METH dependence.","method":"Dual-luciferase reporter assay, stereotaxic injection of antagomir/agomir, western blot, behavioral CPP assay in rats","journal":"Journal of ethnopharmacology","confidence":"Medium","confidence_rationale":"Tier 2–3 — luciferase validation plus in vivo stereotaxic manipulation with behavioral readout","pmids":["37182675"],"is_preprint":false},{"year":2023,"finding":"Haploinsufficiency of both Gabra1 and Gabrg2 in mice results in spontaneous seizures, reduced GABA-A receptor α1, β2, and γ2 subunit expression across brain regions, reduced electroretinography oscillatory potential, and optic nerve degeneration with increased G-ratio indicating impaired axonal myelination.","method":"EEG, western blot, immunohistochemistry, electron microscopy, electroretinography, visual evoked potential in double-heterozygous knockout mice","journal":"Experimental neurology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in genetic mouse model but involves combined Gabra1/Gabrg2 haploinsufficiency","pmids":["37703949"],"is_preprint":false}],"current_model":"GABRA1 encodes the α1 subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates fast inhibitory neurotransmission; pathogenic mutations cause loss of function through multiple mechanisms including reduced GABA-evoked channel currents (impaired gating), ER retention with activation of ERAD and the unfolded protein response, NMD of truncated transcripts, reduced cell-surface trafficking, and impaired synaptic clustering, while rare gain-of-sensitivity variants produce a left-shifted GABA dose-response; transcription of GABRA1 is epigenetically regulated by class I HDACs at its promoter, and its expression is post-transcriptionally regulated by miRNAs including miR-129-2-3p and miR-181a-5p."},"narrative":{"teleology":[{"year":2002,"claim":"Establishing that GABRA1 is a disease gene: the Ala322Asp mutation was shown to reduce GABA-activated currents, directly linking α1 subunit loss-of-function to juvenile myoclonic epilepsy and proving that impaired inhibitory neurotransmission causes seizures.","evidence":"In vitro electrophysiology of mutant GABA-A receptors in heterologous cells","pmids":["11992121"],"confidence":"High","gaps":["Single mutation studied; spectrum of mechanisms across other variants unknown","No trafficking or protein stability data for this variant","In vivo confirmation in animal models not performed"]},{"year":2009,"claim":"Revealing that truncating GABRA1 mutations are eliminated by two distinct quality-control mechanisms—NMD degrades the mutant mRNA, while residual protein is eliminated by ERAD with enhanced chaperone association—explaining how premature termination codons cause near-complete loss of α1 subunit.","evidence":"Minigene NMD assay, UPF-1 siRNA rescue, pulse-chase ERAD assay, chaperone co-immunoprecipitation in neurons and HEK293 cells","pmids":["19261879"],"confidence":"High","gaps":["Whether all PTC variants activate both NMD and ERAD equally was untested","UPR activation by these truncations not assessed"]},{"year":2016,"claim":"Demonstrating that loss-of-function is the convergent mechanism across the phenotypic spectrum of GABRA1 epilepsies—from mild epilepsy to severe encephalopathy—without a clear genotype-phenotype correlation at the electrophysiology level.","evidence":"Two-electrode voltage clamp in Xenopus oocytes for four distinct mutations from an international cohort","pmids":["27521439"],"confidence":"High","gaps":["Trafficking and surface expression not evaluated","Gain-of-function variants not yet identified"]},{"year":2017,"claim":"Identifying epigenetic regulation of GABRA1 transcription: class I HDACs (HDAC1-3) mediate ethanol-induced histone deacetylation at the Gabra1 promoter to suppress expression, and targeted histone acetylation via CRISPR dCas9-P300 prevents this downregulation.","evidence":"HDAC inhibitors, siRNA knockdown, CRISPR dCas9-P300 epigenome editing, ChIP for histone marks in cortical neurons","pmids":["28798030"],"confidence":"High","gaps":["Whether HDAC-mediated regulation of GABRA1 is relevant beyond ethanol exposure is unclear","In vivo confirmation of epigenome editing not performed"]},{"year":2019,"claim":"Establishing that epileptic encephalopathy-associated GABRA1 missense mutations impair multiple aspects of receptor biology—cell-surface expression, ER processing, synaptic clustering, channel function, and GABA binding—providing a multi-hit model for severe phenotypes.","evidence":"Whole-cell patch clamp, surface biotinylation, confocal immunofluorescence for clustering, ER processing assays in HEK293 cells and neurons for five de novo variants","pmids":["31056671"],"confidence":"High","gaps":["Relative contribution of each defect (trafficking vs. gating vs. clustering) to disease severity unknown","No in vivo knockin models"]},{"year":2019,"claim":"Demonstrating that pharmacological rescue of GABRA1 variant dysfunction is feasible: verapamil fully restores R214C receptor function by increasing single-channel open time, whereas diazepam and insulin only partially rescue currents.","evidence":"Whole-cell, macro-patch, and single-channel recordings; surface biotinylation in HEK293 cells","pmids":["31707987"],"confidence":"High","gaps":["Verapamil rescue mechanism at the molecular level not defined","In vivo therapeutic efficacy not tested"]},{"year":2020,"claim":"Revealing that not all pathogenic GABRA1 variants are loss-of-function: the p.Ala332Val variant produces a gain-of-sensitivity phenotype with left-shifted GABA potency and altered desensitization, expanding the mechanistic spectrum.","evidence":"Two-electrode voltage clamp, radioligand displacement, surface protein quantification in Xenopus oocytes","pmids":["32047208"],"confidence":"High","gaps":["Whether gain-of-sensitivity variants require different therapeutic strategies is untested","Single variant characterized"]},{"year":2020,"claim":"Providing in vivo vertebrate evidence for GABRA1 loss-of-function: zebrafish gabra1 knockdown causes hypomotility rescued by wild-type but not pathogenic human GABRA1, confirming the disease mechanism in an organismal context.","evidence":"Morpholino knockdown and mRNA rescue in zebrafish with behavioral analysis","pmids":["32205311"],"confidence":"Medium","gaps":["Morpholino off-target effects limit confidence","Neurophysiological basis of behavioral phenotype not characterized"]},{"year":2021,"claim":"Distinguishing gating from trafficking defects across GABA-A receptor subunits: GABRA1 Dravet syndrome variants primarily impair channel gating with relatively preserved surface expression, contrasting with γ2 subunit variants that predominantly affect trafficking.","evidence":"Whole-cell patch clamp and surface biotinylation for multiple α1 variants compared with γ2 variants in HEK293 cells","pmids":["34095830"],"confidence":"High","gaps":["Whether gating-deficient variants respond differently to pharmacological chaperones is unknown","Subunit-specific rescue strategies not developed"]},{"year":2021,"claim":"Identifying post-transcriptional regulation of GABRA1 by miRNAs: miR-129-2-3p and miR-181a-5p directly target the GABRA1 3′UTR, and in vivo manipulation of these miRNAs modulates seizure activity and drug-seeking behavior through GABRA1 expression changes.","evidence":"Luciferase reporter assays, antagomir/agomir injections, EEG and behavioral CPP assays in rat models","pmids":["34029007","37182675"],"confidence":"Medium","gaps":["Relative contribution of each miRNA to endogenous GABRA1 levels unknown","Whether miRNA-mediated regulation is region-specific in the brain not established"]},{"year":2022,"claim":"Identifying T292 as a critical gating residue with bidirectional effects: T292S increases and T292I decreases GABA-evoked currents and single-channel open time, establishing that a single position can produce both gain- and loss-of-function depending on the substitution.","evidence":"Whole-cell and single-channel patch-clamp recordings in HEK293 cells","pmids":["35269865"],"confidence":"High","gaps":["Structural basis for opposite effects of Ser vs. Ile substitution at T292 not resolved","Clinical severity correlation for these variants not established"]},{"year":2023,"claim":"Demonstrating compound haploinsufficiency: combined Gabra1/Gabrg2 heterozygosity causes spontaneous seizures, reduced multi-subunit GABA-A receptor expression, and optic nerve degeneration with impaired myelination, revealing non-neuronal consequences of GABA-A receptor deficiency.","evidence":"EEG, western blot, immunohistochemistry, electron microscopy, electroretinography in double-heterozygous knockout mice","pmids":["37703949"],"confidence":"Medium","gaps":["Whether myelination defect is cell-autonomous or secondary to seizure activity is unknown","Contribution of Gabra1 alone versus combined haploinsufficiency cannot be separated"]},{"year":2024,"claim":"Zebrafish germline gabra1 knockout reveals compensatory downregulation of other α subunits and widespread proteomic changes in synaptic vesicle, transport, and mitochondrial pathways, suggesting GABRA1 loss propagates beyond GABAergic transmission.","evidence":"Germline nonsense mutant zebrafish with behavioral analysis, qPCR, and quantitative proteomics","pmids":["38908344"],"confidence":"Medium","gaps":["Proteomic changes may be secondary to chronic seizure-like activity rather than direct α1 loss","Mammalian validation of compensatory subunit changes needed"]},{"year":null,"claim":"Key unresolved questions include: the structural basis for why specific residue substitutions produce gain- versus loss-of-function; whether distinct mutation mechanisms (gating vs. trafficking vs. NMD) predict clinical severity or drug responsiveness; and whether pharmacological rescue strategies effective in heterologous cells (e.g., verapamil) translate to in vivo therapeutic benefit.","evidence":"","pmids":[],"confidence":"High","gaps":["No high-resolution structure of disease-mutant α1-containing GABA-A receptors","No genotype-stratified therapeutic trials","Mechanism of verapamil rescue at the channel level undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[0,2,4,7]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[5,7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,4,9]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1,3,9]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[0,2,3,4,6,7]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[1,3,9]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[0,2,6]}],"complexes":["GABA-A receptor (α1β2γ2 heteropentamer)"],"partners":["GABRB2","GABRG2"],"other_free_text":[]},"mechanistic_narrative":"GABRA1 encodes the α1 subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates fast inhibitory neurotransmission in the brain. Pathogenic missense mutations predominantly impair receptor gating—reducing GABA-evoked currents, single-channel open time, and GABA binding potency—while truncating and some missense variants cause endoplasmic reticulum retention, activation of the unfolded protein response and ERAD, nonsense-mediated mRNA decay, and reduced cell-surface trafficking and synaptic clustering [PMID:11992121, PMID:19261879, PMID:31056671, PMID:34095830]. Rare variants at residue T292 or in TM3 produce gain-of-sensitivity phenotypes with left-shifted GABA dose-response curves, demonstrating that both loss- and gain-of-function mechanisms underlie GABRA1-associated epilepsies ranging from juvenile myoclonic epilepsy to Dravet syndrome and early-onset epileptic encephalopathy [PMID:32047208, PMID:35269865, PMID:27521439]. Transcription of GABRA1 is regulated by class I HDAC-dependent histone deacetylation at its promoter, and its mRNA is post-transcriptionally targeted by miR-129-2-3p and miR-181a-5p [PMID:28798030, PMID:34029007, PMID:37182675]."},"prefetch_data":{"uniprot":{"accession":"P14867","full_name":"Gamma-aminobutyric acid receptor subunit alpha-1","aliases":["GABA(A) receptor subunit alpha-1","GABAAR subunit alpha-1"],"length_aa":456,"mass_kda":51.8,"function":"Alpha subunit of the heteropentameric ligand-gated chloride channel gated by Gamma-aminobutyric acid (GABA), a major inhibitory neurotransmitter in the brain (PubMed:23909897, PubMed:25489750, PubMed:29950725, PubMed:30602789). GABA-gated chloride channels, also named GABA(A) receptors (GABAAR), consist of five subunits arranged around a central pore and contain GABA active binding site(s) located at the alpha and beta subunit interface(s) (PubMed:29950725, PubMed:30602789). When activated by GABA, GABAARs selectively allow the flow of chloride anions across the cell membrane down their electrochemical gradient (PubMed:23909897, PubMed:29950725, PubMed:30602789). Alpha-1/GABRA1-containing GABAARs are largely synaptic (By similarity). Chloride influx into the postsynaptic neuron following GABAAR opening decreases the neuron ability to generate a new action potential, thereby reducing nerve transmission (By similarity). GABAARs containing alpha-1 and beta-2 or -3 subunits exhibit synaptogenic activity; the gamma-2 subunit being necessary but not sufficient to induce rapid synaptic contacts formation (PubMed:23909897, PubMed:25489750). GABAARs function also as histamine receptor where histamine binds at the interface of two neighboring beta subunits and potentiates GABA response (By similarity). GABAARs containing alpha, beta and epsilon subunits also permit spontaneous chloride channel activity while preserving the structural information required for GABA-gated openings (By similarity). Alpha-1-mediated plasticity in the orbitofrontal cortex regulates context-dependent action selection (By similarity). Together with rho subunits, may also control neuronal and glial GABAergic transmission in the cerebellum (By similarity)","subcellular_location":"Postsynaptic cell membrane; Cell membrane; Cytoplasmic vesicle membrane","url":"https://www.uniprot.org/uniprotkb/P14867/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GABRA1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GABRA1","total_profiled":1310},"omim":[{"mim_id":"620465","title":"EPILEPSY, EARLY-ONSET, 3, WITH OR WITHOUT DEVELOPMENTAL DELAY; EPEO3","url":"https://www.omim.org/entry/620465"},{"mim_id":"619964","title":"DEVELOPMENTAL DELAY, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES, WITH OR WITHOUT SEIZURES; DEDISB","url":"https://www.omim.org/entry/619964"},{"mim_id":"618559","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 79; DEE79","url":"https://www.omim.org/entry/618559"},{"mim_id":"615744","title":"DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 19; DEE19","url":"https://www.omim.org/entry/615744"},{"mim_id":"612849","title":"UBIQUITIN-SPECIFIC PEPTIDASE 46; USP46","url":"https://www.omim.org/entry/612849"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":52.4},{"tissue":"retina","ntpm":16.5}],"url":"https://www.proteinatlas.org/search/GABRA1"},"hgnc":{"alias_symbol":["EJM5"],"prev_symbol":[]},"alphafold":{"accession":"P14867","domains":[{"cath_id":"2.70.170.10","chopping":"48-248","consensus_level":"medium","plddt":94.642,"start":48,"end":248},{"cath_id":"1.20.58.390","chopping":"251-342_417-443","consensus_level":"high","plddt":93.8876,"start":251,"end":443}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P14867","model_url":"https://alphafold.ebi.ac.uk/files/AF-P14867-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P14867-F1-predicted_aligned_error_v6.png","plddt_mean":81.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GABRA1","jax_strain_url":"https://www.jax.org/strain/search?query=GABRA1"},"sequence":{"accession":"P14867","fasta_url":"https://rest.uniprot.org/uniprotkb/P14867.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P14867/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P14867"}},"corpus_meta":[{"pmid":"11992121","id":"PMC_11992121","title":"Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy.","date":"2002","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11992121","citation_count":459,"is_preprint":false},{"pmid":"24623842","id":"PMC_24623842","title":"GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.","date":"2014","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24623842","citation_count":209,"is_preprint":false},{"pmid":"27521439","id":"PMC_27521439","title":"Phenotypic spectrum of GABRA1: From generalized epilepsies to severe epileptic encephalopathies.","date":"2016","source":"Neurology","url":"https://pubmed.ncbi.nlm.nih.gov/27521439","citation_count":113,"is_preprint":false},{"pmid":"16792556","id":"PMC_16792556","title":"Association between GABRA1 and drinking behaviors in the collaborative study on the genetics of alcoholism sample.","date":"2006","source":"Alcoholism, clinical and experimental research","url":"https://pubmed.ncbi.nlm.nih.gov/16792556","citation_count":79,"is_preprint":false},{"pmid":"26918889","id":"PMC_26918889","title":"De novo GABRA1 mutations in Ohtahara and West syndromes.","date":"2016","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/26918889","citation_count":73,"is_preprint":false},{"pmid":"35718920","id":"PMC_35718920","title":"Molecular and clinical descriptions of patients with GABAA receptor gene variants (GABRA1, GABRB2, GABRB3, GABRG2): A cohort study, review of literature, and genotype-phenotype correlation.","date":"2022","source":"Epilepsia","url":"https://pubmed.ncbi.nlm.nih.gov/35718920","citation_count":67,"is_preprint":false},{"pmid":"30417952","id":"PMC_30417952","title":"Chronic alcohol exposure induced gut microbiota dysbiosis and its correlations with neuropsychic behaviors and brain BDNF/Gabra1 changes in mice.","date":"2018","source":"BioFactors (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/30417952","citation_count":67,"is_preprint":false},{"pmid":"19261879","id":"PMC_19261879","title":"Two molecular pathways (NMD and ERAD) contribute to a genetic epilepsy associated with the GABA(A) receptor GABRA1 PTC mutation, 975delC, S326fs328X.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19261879","citation_count":55,"is_preprint":false},{"pmid":"1330891","id":"PMC_1330891","title":"Confirmation of the localization of the human GABAA receptor alpha 1-subunit gene (GABRA1) to distal 5q by linkage analysis.","date":"1992","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/1330891","citation_count":45,"is_preprint":false},{"pmid":"16530959","id":"PMC_16530959","title":"Genetic analysis of the GABRA1 gene in patients with essential tremor.","date":"2006","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16530959","citation_count":44,"is_preprint":false},{"pmid":"34001135","id":"PMC_34001135","title":"Mir-139-5p inhibits glioma cell proliferation and progression by targeting GABRA1.","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34001135","citation_count":43,"is_preprint":false},{"pmid":"16839746","id":"PMC_16839746","title":"Mutations in the GABRA1 and EFHC1 genes are rare in familial juvenile myoclonic epilepsy.","date":"2006","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/16839746","citation_count":38,"is_preprint":false},{"pmid":"14706423","id":"PMC_14706423","title":"Possible association between a haplotype of the GABA-A receptor alpha 1 subunit gene (GABRA1) and mood disorders.","date":"2004","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/14706423","citation_count":38,"is_preprint":false},{"pmid":"31056671","id":"PMC_31056671","title":"Altered inhibitory synapses in de novo GABRA5 and GABRA1 mutations associated with early onset epileptic encephalopathies.","date":"2019","source":"Brain : a journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31056671","citation_count":36,"is_preprint":false},{"pmid":"34095830","id":"PMC_34095830","title":"Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABAA receptors.","date":"2021","source":"Brain communications","url":"https://pubmed.ncbi.nlm.nih.gov/34095830","citation_count":35,"is_preprint":false},{"pmid":"26189305","id":"PMC_26189305","title":"ABCB1, ABCC2, SCN1A, SCN2A, GABRA1 gene polymorphisms and drug resistant epilepsy in the Chinese Han population.","date":"2015","source":"Die Pharmazie","url":"https://pubmed.ncbi.nlm.nih.gov/26189305","citation_count":32,"is_preprint":false},{"pmid":"22038115","id":"PMC_22038115","title":"Identification of GABRA1 and LAMA2 as new DNA methylation markers in colorectal cancer.","date":"2011","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/22038115","citation_count":24,"is_preprint":false},{"pmid":"28864462","id":"PMC_28864462","title":"Rapid whole-genome sequencing identifies a novel GABRA1 variant associated with West syndrome.","date":"2017","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/28864462","citation_count":23,"is_preprint":false},{"pmid":"32047208","id":"PMC_32047208","title":"A novel de novo variant of GABRA1 causes increased sensitivity for GABA in vitro.","date":"2020","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/32047208","citation_count":22,"is_preprint":false},{"pmid":"28798030","id":"PMC_28798030","title":"Ethanol Exposure Regulates Gabra1 Expression via Histone Deacetylation at the Promoter in Cultured Cortical Neurons.","date":"2017","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/28798030","citation_count":19,"is_preprint":false},{"pmid":"34029007","id":"PMC_34029007","title":"Inhibition of microRNA-129-2-3p protects against refractory temporal lobe epilepsy by regulating GABRA1.","date":"2021","source":"Brain and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/34029007","citation_count":19,"is_preprint":false},{"pmid":"34740144","id":"PMC_34740144","title":"GABRA1 and GABRA6 gene mutations in idiopathic generalized epilepsy patients.","date":"2021","source":"Seizure","url":"https://pubmed.ncbi.nlm.nih.gov/34740144","citation_count":18,"is_preprint":false},{"pmid":"32205311","id":"PMC_32205311","title":"Abnormal expression of GABAA receptor subunits and hypomotility upon loss of gabra1 in zebrafish.","date":"2020","source":"Biology open","url":"https://pubmed.ncbi.nlm.nih.gov/32205311","citation_count":18,"is_preprint":false},{"pmid":"38269327","id":"PMC_38269327","title":"De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects.","date":"2024","source":"Frontiers in molecular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/38269327","citation_count":17,"is_preprint":false},{"pmid":"15955415","id":"PMC_15955415","title":"Mutation screen of GABRA1, GABRB2 and GABRG2 genes in Japanese patients with absence seizures.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15955415","citation_count":17,"is_preprint":false},{"pmid":"31707987","id":"PMC_31707987","title":"Pathophysiology of and therapeutic options for a GABRA1 variant linked to epileptic encephalopathy.","date":"2019","source":"Molecular brain","url":"https://pubmed.ncbi.nlm.nih.gov/31707987","citation_count":15,"is_preprint":false},{"pmid":"35269865","id":"PMC_35269865","title":"Distinct Functional Alterations and Therapeutic Options of Two Pathological De Novo Variants of the T292 Residue of GABRA1 Identified in Children with Epileptic Encephalopathy and Neurodevelopmental Disorders.","date":"2022","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/35269865","citation_count":15,"is_preprint":false},{"pmid":"26249742","id":"PMC_26249742","title":"Polymorphism rs4263535 in GABRA1 intron 4 was related to deeper sedation by intravenous midazolam.","date":"2015","source":"The Journal of international medical research","url":"https://pubmed.ncbi.nlm.nih.gov/26249742","citation_count":14,"is_preprint":false},{"pmid":"27613244","id":"PMC_27613244","title":"Do the exome: A case of Williams-Beuren syndrome with severe epilepsy due to a truncating de novo variant in GABRA1.","date":"2016","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27613244","citation_count":14,"is_preprint":false},{"pmid":"14631097","id":"PMC_14631097","title":"Absence of GABRA1 Ala322Asp mutation in juvenile myoclonic epilepsy families from India.","date":"2003","source":"Journal of genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14631097","citation_count":12,"is_preprint":false},{"pmid":"16256272","id":"PMC_16256272","title":"Mutations in GABRA1, GABRA5, GABRG2 and GABRD receptor genes are not a major factor in the pathogenesis of familial focal epilepsy preceded by febrile seizures.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/16256272","citation_count":12,"is_preprint":false},{"pmid":"28540321","id":"PMC_28540321","title":"Novel SCN1A and GABRA1 Gene Mutations With Diverse Phenotypic Features and the Question on the Existence of a Broader Spectrum of Dravet Syndrome.","date":"2017","source":"Child neurology open","url":"https://pubmed.ncbi.nlm.nih.gov/28540321","citation_count":10,"is_preprint":false},{"pmid":"37182675","id":"PMC_37182675","title":"Rhynchophylline inhibits methamphetamine dependence via modulating the miR-181a-5p/GABRA1 axis.","date":"2023","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37182675","citation_count":9,"is_preprint":false},{"pmid":"27245092","id":"PMC_27245092","title":"Evaluating the Role of Genetic Variants on first-line antiepileptic drug response in North India: Significance of SCN1A and GABRA1 Gene Variants in Phenytoin Monotherapy and its Serum Drug Levels.","date":"2016","source":"CNS neuroscience & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/27245092","citation_count":9,"is_preprint":false},{"pmid":"16569738","id":"PMC_16569738","title":"Allelic variants of the gamma-aminobutyric acid-A receptor alpha1-subunit gene (GABRA1) are not associated with idiopathic gonadotropin-dependent precocious puberty in girls with and without electroencephalographic abnormalities.","date":"2006","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/16569738","citation_count":9,"is_preprint":false},{"pmid":"37809401","id":"PMC_37809401","title":"Pathogenic variants of human GABRA1 gene associated with epilepsy: A computational approach.","date":"2023","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/37809401","citation_count":8,"is_preprint":false},{"pmid":"37434477","id":"PMC_37434477","title":"Vinpocetine improved neuropsychiatric and epileptic outcomes in a patient with a GABRA1 loss-of-function variant.","date":"2023","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37434477","citation_count":8,"is_preprint":false},{"pmid":"35173461","id":"PMC_35173461","title":"GABRA1 and GABRB2 Polymorphisms are Associated with Propofol Susceptibility.","date":"2022","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35173461","citation_count":8,"is_preprint":false},{"pmid":"35689264","id":"PMC_35689264","title":"Long non-coding RNA Gm37494 alleviates osteoarthritis chondrocyte injury via the microRNA-181a-5p/GABRA1 axis.","date":"2022","source":"Journal of orthopaedic surgery and research","url":"https://pubmed.ncbi.nlm.nih.gov/35689264","citation_count":7,"is_preprint":false},{"pmid":"27439062","id":"PMC_27439062","title":"c-Jun N-terminal Kinase mediates prostaglandin-induced sympathoexcitation in rats with chronic heart failure by reducing GAD1 and GABRA1 expression.","date":"2016","source":"Acta physiologica (Oxford, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27439062","citation_count":6,"is_preprint":false},{"pmid":"37703949","id":"PMC_37703949","title":"Epilepsy plus blindness in microdeletion of GABRA1 and GABRG2 in mouse and human.","date":"2023","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/37703949","citation_count":5,"is_preprint":false},{"pmid":"35520951","id":"PMC_35520951","title":"Successful use of perampanel in GABRA1-related myoclonic epilepsy with photosensitivity.","date":"2022","source":"Epilepsy & behavior reports","url":"https://pubmed.ncbi.nlm.nih.gov/35520951","citation_count":5,"is_preprint":false},{"pmid":"32102148","id":"PMC_32102148","title":"[Clinical phenotypes of epilepsy associated with GABRA1 gene variants].","date":"2020","source":"Zhonghua er ke za zhi = Chinese journal of pediatrics","url":"https://pubmed.ncbi.nlm.nih.gov/32102148","citation_count":4,"is_preprint":false},{"pmid":"38908344","id":"PMC_38908344","title":"Characterization of the zebrafish gabra1sa43718/sa43718 germline loss of function allele confirms a function for Gabra1 in motility and nervous system development.","date":"2024","source":"Differentiation; research in biological diversity","url":"https://pubmed.ncbi.nlm.nih.gov/38908344","citation_count":3,"is_preprint":false},{"pmid":"39651292","id":"PMC_39651292","title":"GABRA1 frameshift variants impair GABAA receptor proteostasis.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39651292","citation_count":3,"is_preprint":false},{"pmid":"36747751","id":"PMC_36747751","title":"Characterization of the zebrafish gabra1 germline loss of function allele confirms a function for Gabra1 in motility and nervous system development.","date":"2023","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/36747751","citation_count":2,"is_preprint":false},{"pmid":"36584483","id":"PMC_36584483","title":"Genetic interaction between GABRA1 and ERBB4 variants in the pathogenesis of genetic generalized epilepsy.","date":"2022","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/36584483","citation_count":2,"is_preprint":false},{"pmid":"41643875","id":"PMC_41643875","title":"Porcine Cardiac Blood processed Kansui Radix alleviates PTZ-induced epileptic damage in mice via the bidirectional regulation of GABRA1 and cGMP/PKG signaling pathway.","date":"2026","source":"Journal of ethnopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/41643875","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.30.685505","title":"Kv2.1-Kv6.4 subunits deficiency impairs inhibitory signaling and visual circuit dynamics in zebrafish","date":"2025-10-31","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.30.685505","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.02.651974","title":"Loss of age-associated increase in m<sup>6</sup>A-modified RNA contributes to GABAergic dysregulation in Alzheimer’s disease","date":"2025-05-06","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.02.651974","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.22.684016","title":"Proteomic characterization of neuronal extracellular vesicle interactomes in Alzheimer’s disease mouse model through TurboID-based proximity labeling","date":"2025-10-23","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.22.684016","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.09.632229","title":"MicroRNA-502-3p modulates the GABA A subunits, synaptic proteins and mitochondrial morphology in hippocampal neurons","date":"2025-01-13","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.09.632229","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.28.625971","title":"<i>GABRA1</i> frameshift variants impair GABA<sub>A</sub>receptor proteostasis","date":"2024-11-29","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.28.625971","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.28.656556","title":"Prenatal alcohol exposure dysregulates the expression of clock genes and alters rhythmic behaviour in mice","date":"2025-05-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.28.656556","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.30.621141","title":"The persistent effects of predator odor stressor enhance interoceptive sensitivity to alcohol through GABA<sub>A</sub>receptor adaptations in the prelimbic cortex in male, but not female rats","date":"2024-10-31","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.30.621141","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":29928,"output_tokens":4141,"usd":0.07595},"stage2":{"model":"claude-opus-4-6","input_tokens":7623,"output_tokens":3232,"usd":0.178372},"total_usd":0.254322,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"The Ala322Asp missense mutation in GABRA1 (encoding the GABA-A receptor α1 subunit) causes reduced amplitude of GABA-activated currents in vitro, demonstrating loss-of-function of this inhibitory ligand-gated ion channel and establishing that seizures in juvenile myoclonic epilepsy result from reduced inhibitory neurotransmission.\",\n      \"method\": \"In vitro electrophysiology of mutant GABA-A receptors expressing the Ala322Asp variant\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional assay with direct current measurement, foundational paper with 459 citations\",\n      \"pmids\": [\"11992121\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The GABRA1 PTC mutation 975delC (S326fs328X) triggers nonsense-mediated mRNA decay (NMD) that substantially reduces mutant mRNA levels; residual mutant protein undergoes endoplasmic reticulum-associated degradation (ERAD) with enhanced association with molecular chaperones, demonstrating that both NMD and ERAD contribute to loss of α1 subunit and epileptogenesis.\",\n      \"method\": \"Minigene NMD assay, ribosome inhibition, siRNA knockdown of hUPF-1, pulse-chase protein stability assay, co-immunoprecipitation with chaperones in neurons and non-neuronal cells\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods (NMD reporter, siRNA rescue, ERAD assay, chaperone co-IP) in a single rigorous study\",\n      \"pmids\": [\"19261879\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Functional analysis of selected GABRA1 mutations using the Xenopus laevis oocyte expression system revealed loss of function for all four tested mutations, without a clear genotype-phenotype correlation, confirming that loss-of-function is the primary mechanism across the phenotypic spectrum from mild epilepsy to severe epileptic encephalopathy.\",\n      \"method\": \"Two-electrode voltage clamp electrophysiology in Xenopus laevis oocytes expressing mutant GABA-A receptors\",\n      \"journal\": \"Neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro electrophysiology in multiple mutations, replicated across international cohort\",\n      \"pmids\": [\"27521439\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Multiple de novo GABRA1 mutations associated with early-onset epileptic encephalopathy (P260S, L296S, W315L, R112Q, N115D) cause reduced cell-surface and total GABA-A receptor expression, altered endoplasmic reticulum processing, impaired synaptic clustering, reduced GABA-A receptor function, and decreased GABA binding potency when expressed in neuronal and non-neuronal cells.\",\n      \"method\": \"Whole-cell patch-clamp electrophysiology, surface biotinylation, confocal immunofluorescence for receptor clustering, ER processing assays in HEK293 cells and neurons\",\n      \"journal\": \"Brain : a journal of neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (electrophysiology, surface expression, trafficking, clustering) in a single study\",\n      \"pmids\": [\"31056671\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The GABRA1 R214C variant reduces whole-cell GABA-evoked currents by decreasing single-channel open time and reducing both surface and total GABA-A receptor expression levels; verapamil treatment fully restores receptor function primarily by increasing channel open time, while diazepam and insulin only partially restore currents.\",\n      \"method\": \"Whole-cell, outside-out macro-patch, and cell-attached single-channel patch-clamp recordings; surface biotinylation assay; western blotting in HEK293 cells\",\n      \"journal\": \"Molecular brain\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — single-channel recordings plus surface expression quantification with pharmacological rescue, multiple methods\",\n      \"pmids\": [\"31707987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The de novo GABRA1 variant p.(Ala332Val) in TM3 produces unchanged protein levels and normal cell-surface trafficking but causes a significant left shift in apparent GABA potency (increased sensitivity) and altered desensitization kinetics, as well as a left shift in apparent diazepam potency, representing a gain-of-sensitivity rather than typical loss-of-function.\",\n      \"method\": \"Two-electrode voltage clamp electrophysiology, radioligand displacement assays, surface protein quantification\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro electrophysiology plus radioligand binding with multiple functional readouts\",\n      \"pmids\": [\"32047208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"GABRA1 mutations in Dravet syndrome (L215P, R214C, V287I, R214H) cause defects primarily in receptor gating rather than trafficking, distinguishing α1 subunit variants from γ2 subunit variants (which show mainly trafficking defects), and demonstrating that α1 and β2 subunit variants are less tolerated and express well but are functionally deficient.\",\n      \"method\": \"Whole-cell patch-clamp electrophysiology, surface biotinylation, total protein quantification in HEK293 cells\",\n      \"journal\": \"Brain communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — electrophysiology and trafficking assays across multiple variants with comparative analysis\",\n      \"pmids\": [\"34095830\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"The GABRA1 T292S variant significantly increases GABA-evoked whole-cell currents (left-shifted dose-response, increased single-channel open time and open probability), while the T292I variant at the same residue markedly reduces GABA-evoked currents (right-shifted dose-response, decreased maximum response, reduced open time), establishing T292 as a critical residue controlling GABA-A receptor channel gating with bidirectional effects.\",\n      \"method\": \"Whole-cell and single-channel patch-clamp recordings in HEK293 cells expressing recombinant GABA-A receptors\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — single-channel recordings plus dose-response analysis for two variants at same residue, mechanistically rigorous\",\n      \"pmids\": [\"35269865\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Ethanol exposure reduces GABRA1 (α1 subunit) expression in cultured cortical neurons through class I HDAC-mediated histone deacetylation at the Gabra1 promoter; pharmacological inhibition or siRNA knockdown of HDAC1-3 prevents ethanol-induced reduction, and targeted histone acetylation using CRISPR dCas9-P300 at the Gabra1 promoter prevents the decrease in expression.\",\n      \"method\": \"CRISPR dCas9-P300 epigenome editing, HDAC inhibitors, siRNA knockdown, ChIP for histone acetylation marks, qPCR and western blot in cortical neurons\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal approaches including targeted epigenome editing with functional readout\",\n      \"pmids\": [\"28798030\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Four clinical GABRA1 frameshift variants (K401fs, S326fs, V290fs, F272fs) that truncate one to three transmembrane helices all show significantly reduced trafficking to the cell surface resulting in non-functional ion channels; variants exhibit ER retention and activate the unfolded protein response (UPR) to varying extents depending on the specific transmembrane domain deletions.\",\n      \"method\": \"Surface biotinylation, immunofluorescence for ER markers, UPR reporter assays, patch-clamp electrophysiology in HEK293T cells\",\n      \"journal\": \"bioRxiv : the preprint server for biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in single preprint study not yet peer-reviewed\",\n      \"pmids\": [\"39651292\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Loss of gabra1 in zebrafish (morpholino knockdown) results in hypomotility and altered expression of other GABA-A receptor subunits; expression of wild-type human GABRA1 partially rescues the hypomotility phenotype, while the pathogenic c.875C>T variant fails to rescue, establishing loss-of-function as the disease mechanism.\",\n      \"method\": \"Zebrafish morpholino knockdown, behavioral analysis, rescue with wild-type versus mutant human GABRA1 mRNA\",\n      \"journal\": \"Biology open\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with rescue experiment, but morpholino-based knockdown has limitations\",\n      \"pmids\": [\"32205311\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In chronic heart failure rats, JNK activation downstream of prostaglandin E2/EP3 receptor signaling reduces GABRA1 (GABA-A receptor α1 subunit) expression in the paraventricular nucleus; JNK inhibitor SP600125 normalizes both sympathoexcitation and GABRA1 expression, placing GABRA1 downstream of the PGE2-PTGER3-JNK signaling axis.\",\n      \"method\": \"Pharmacological inhibition (SP600125 JNK inhibitor), western blot, qPCR, renal sympathetic nerve discharge measurement in rat CHF model\",\n      \"journal\": \"Acta physiologica\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — epistasis via pharmacological inhibition with in vivo functional readout\",\n      \"pmids\": [\"27439062\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-139-5p directly targets GABRA1 mRNA, and overexpression of miR-139-5p inhibits glioma cell proliferation, migration, and invasion; upregulation of GABRA1 reverses these inhibitory effects, establishing a miR-139-5p/GABRA1 regulatory axis in glioma.\",\n      \"method\": \"Rescue experiments, cell proliferation/migration/invasion assays, luciferase reporter (implied), western blot in glioma cell lines\",\n      \"journal\": \"Journal of translational medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — rescue experiments in cancer cell lines establish target relationship but mechanism is indirect\",\n      \"pmids\": [\"34001135\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"miR-129-2-3p directly targets GABRA1 3'UTR as validated by luciferase reporter assay; in a rat kainic acid seizure model, miR-129-2-3p is upregulated while GABRA1 is downregulated, and in vivo knockdown of miR-129-2-3p alleviates seizure-like EEG findings through upregulation of GABRA1.\",\n      \"method\": \"Luciferase reporter assay, qPCR, western blot, EEG recording, in vivo antagomir injection in rat KA seizure model\",\n      \"journal\": \"Brain and behavior\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — luciferase validation of direct targeting plus in vivo functional rescue\",\n      \"pmids\": [\"34029007\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Loss-of-function of zebrafish gabra1 (sa43718 nonsense allele) results in light-induced hypermotility, decreased mRNA expression of other GABA-A receptor α subunits (gabra2, gabra3, gabra5), and abnormal expression of proteins regulating synaptic vesicle fusion, vesicle transport, synapse development, and mitochondrial complexes, as identified by proteomics.\",\n      \"method\": \"Germline mutant zebrafish behavioral analysis, qPCR, quantitative proteomics\",\n      \"journal\": \"Differentiation; research in biological diversity\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — germline loss-of-function with proteomics and behavioral phenotyping in vertebrate model\",\n      \"pmids\": [\"38908344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"miR-181a-5p directly targets GABRA1 in vivo and in vitro; rhynchophylline reverses methamphetamine-induced conditioned place preference by suppressing miR-181a-5p, thereby restoring GABRA1 expression, establishing the miR-181a-5p/GABRA1 axis in METH dependence.\",\n      \"method\": \"Dual-luciferase reporter assay, stereotaxic injection of antagomir/agomir, western blot, behavioral CPP assay in rats\",\n      \"journal\": \"Journal of ethnopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — luciferase validation plus in vivo stereotaxic manipulation with behavioral readout\",\n      \"pmids\": [\"37182675\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Haploinsufficiency of both Gabra1 and Gabrg2 in mice results in spontaneous seizures, reduced GABA-A receptor α1, β2, and γ2 subunit expression across brain regions, reduced electroretinography oscillatory potential, and optic nerve degeneration with increased G-ratio indicating impaired axonal myelination.\",\n      \"method\": \"EEG, western blot, immunohistochemistry, electron microscopy, electroretinography, visual evoked potential in double-heterozygous knockout mice\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in genetic mouse model but involves combined Gabra1/Gabrg2 haploinsufficiency\",\n      \"pmids\": [\"37703949\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GABRA1 encodes the α1 subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates fast inhibitory neurotransmission; pathogenic mutations cause loss of function through multiple mechanisms including reduced GABA-evoked channel currents (impaired gating), ER retention with activation of ERAD and the unfolded protein response, NMD of truncated transcripts, reduced cell-surface trafficking, and impaired synaptic clustering, while rare gain-of-sensitivity variants produce a left-shifted GABA dose-response; transcription of GABRA1 is epigenetically regulated by class I HDACs at its promoter, and its expression is post-transcriptionally regulated by miRNAs including miR-129-2-3p and miR-181a-5p.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GABRA1 encodes the α1 subunit of the GABA-A receptor, a ligand-gated chloride channel that mediates fast inhibitory neurotransmission in the brain. Pathogenic missense mutations predominantly impair receptor gating—reducing GABA-evoked currents, single-channel open time, and GABA binding potency—while truncating and some missense variants cause endoplasmic reticulum retention, activation of the unfolded protein response and ERAD, nonsense-mediated mRNA decay, and reduced cell-surface trafficking and synaptic clustering [PMID:11992121, PMID:19261879, PMID:31056671, PMID:34095830]. Rare variants at residue T292 or in TM3 produce gain-of-sensitivity phenotypes with left-shifted GABA dose-response curves, demonstrating that both loss- and gain-of-function mechanisms underlie GABRA1-associated epilepsies ranging from juvenile myoclonic epilepsy to Dravet syndrome and early-onset epileptic encephalopathy [PMID:32047208, PMID:35269865, PMID:27521439]. Transcription of GABRA1 is regulated by class I HDAC-dependent histone deacetylation at its promoter, and its mRNA is post-transcriptionally targeted by miR-129-2-3p and miR-181a-5p [PMID:28798030, PMID:34029007, PMID:37182675].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Establishing that GABRA1 is a disease gene: the Ala322Asp mutation was shown to reduce GABA-activated currents, directly linking α1 subunit loss-of-function to juvenile myoclonic epilepsy and proving that impaired inhibitory neurotransmission causes seizures.\",\n      \"evidence\": \"In vitro electrophysiology of mutant GABA-A receptors in heterologous cells\",\n      \"pmids\": [\"11992121\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Single mutation studied; spectrum of mechanisms across other variants unknown\", \"No trafficking or protein stability data for this variant\", \"In vivo confirmation in animal models not performed\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Revealing that truncating GABRA1 mutations are eliminated by two distinct quality-control mechanisms—NMD degrades the mutant mRNA, while residual protein is eliminated by ERAD with enhanced chaperone association—explaining how premature termination codons cause near-complete loss of α1 subunit.\",\n      \"evidence\": \"Minigene NMD assay, UPF-1 siRNA rescue, pulse-chase ERAD assay, chaperone co-immunoprecipitation in neurons and HEK293 cells\",\n      \"pmids\": [\"19261879\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether all PTC variants activate both NMD and ERAD equally was untested\", \"UPR activation by these truncations not assessed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Demonstrating that loss-of-function is the convergent mechanism across the phenotypic spectrum of GABRA1 epilepsies—from mild epilepsy to severe encephalopathy—without a clear genotype-phenotype correlation at the electrophysiology level.\",\n      \"evidence\": \"Two-electrode voltage clamp in Xenopus oocytes for four distinct mutations from an international cohort\",\n      \"pmids\": [\"27521439\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trafficking and surface expression not evaluated\", \"Gain-of-function variants not yet identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identifying epigenetic regulation of GABRA1 transcription: class I HDACs (HDAC1-3) mediate ethanol-induced histone deacetylation at the Gabra1 promoter to suppress expression, and targeted histone acetylation via CRISPR dCas9-P300 prevents this downregulation.\",\n      \"evidence\": \"HDAC inhibitors, siRNA knockdown, CRISPR dCas9-P300 epigenome editing, ChIP for histone marks in cortical neurons\",\n      \"pmids\": [\"28798030\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether HDAC-mediated regulation of GABRA1 is relevant beyond ethanol exposure is unclear\", \"In vivo confirmation of epigenome editing not performed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Establishing that epileptic encephalopathy-associated GABRA1 missense mutations impair multiple aspects of receptor biology—cell-surface expression, ER processing, synaptic clustering, channel function, and GABA binding—providing a multi-hit model for severe phenotypes.\",\n      \"evidence\": \"Whole-cell patch clamp, surface biotinylation, confocal immunofluorescence for clustering, ER processing assays in HEK293 cells and neurons for five de novo variants\",\n      \"pmids\": [\"31056671\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of each defect (trafficking vs. gating vs. clustering) to disease severity unknown\", \"No in vivo knockin models\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Demonstrating that pharmacological rescue of GABRA1 variant dysfunction is feasible: verapamil fully restores R214C receptor function by increasing single-channel open time, whereas diazepam and insulin only partially rescue currents.\",\n      \"evidence\": \"Whole-cell, macro-patch, and single-channel recordings; surface biotinylation in HEK293 cells\",\n      \"pmids\": [\"31707987\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Verapamil rescue mechanism at the molecular level not defined\", \"In vivo therapeutic efficacy not tested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealing that not all pathogenic GABRA1 variants are loss-of-function: the p.Ala332Val variant produces a gain-of-sensitivity phenotype with left-shifted GABA potency and altered desensitization, expanding the mechanistic spectrum.\",\n      \"evidence\": \"Two-electrode voltage clamp, radioligand displacement, surface protein quantification in Xenopus oocytes\",\n      \"pmids\": [\"32047208\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether gain-of-sensitivity variants require different therapeutic strategies is untested\", \"Single variant characterized\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Providing in vivo vertebrate evidence for GABRA1 loss-of-function: zebrafish gabra1 knockdown causes hypomotility rescued by wild-type but not pathogenic human GABRA1, confirming the disease mechanism in an organismal context.\",\n      \"evidence\": \"Morpholino knockdown and mRNA rescue in zebrafish with behavioral analysis\",\n      \"pmids\": [\"32205311\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Morpholino off-target effects limit confidence\", \"Neurophysiological basis of behavioral phenotype not characterized\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Distinguishing gating from trafficking defects across GABA-A receptor subunits: GABRA1 Dravet syndrome variants primarily impair channel gating with relatively preserved surface expression, contrasting with γ2 subunit variants that predominantly affect trafficking.\",\n      \"evidence\": \"Whole-cell patch clamp and surface biotinylation for multiple α1 variants compared with γ2 variants in HEK293 cells\",\n      \"pmids\": [\"34095830\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether gating-deficient variants respond differently to pharmacological chaperones is unknown\", \"Subunit-specific rescue strategies not developed\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Identifying post-transcriptional regulation of GABRA1 by miRNAs: miR-129-2-3p and miR-181a-5p directly target the GABRA1 3′UTR, and in vivo manipulation of these miRNAs modulates seizure activity and drug-seeking behavior through GABRA1 expression changes.\",\n      \"evidence\": \"Luciferase reporter assays, antagomir/agomir injections, EEG and behavioral CPP assays in rat models\",\n      \"pmids\": [\"34029007\", \"37182675\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contribution of each miRNA to endogenous GABRA1 levels unknown\", \"Whether miRNA-mediated regulation is region-specific in the brain not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identifying T292 as a critical gating residue with bidirectional effects: T292S increases and T292I decreases GABA-evoked currents and single-channel open time, establishing that a single position can produce both gain- and loss-of-function depending on the substitution.\",\n      \"evidence\": \"Whole-cell and single-channel patch-clamp recordings in HEK293 cells\",\n      \"pmids\": [\"35269865\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for opposite effects of Ser vs. Ile substitution at T292 not resolved\", \"Clinical severity correlation for these variants not established\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Demonstrating compound haploinsufficiency: combined Gabra1/Gabrg2 heterozygosity causes spontaneous seizures, reduced multi-subunit GABA-A receptor expression, and optic nerve degeneration with impaired myelination, revealing non-neuronal consequences of GABA-A receptor deficiency.\",\n      \"evidence\": \"EEG, western blot, immunohistochemistry, electron microscopy, electroretinography in double-heterozygous knockout mice\",\n      \"pmids\": [\"37703949\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether myelination defect is cell-autonomous or secondary to seizure activity is unknown\", \"Contribution of Gabra1 alone versus combined haploinsufficiency cannot be separated\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Zebrafish germline gabra1 knockout reveals compensatory downregulation of other α subunits and widespread proteomic changes in synaptic vesicle, transport, and mitochondrial pathways, suggesting GABRA1 loss propagates beyond GABAergic transmission.\",\n      \"evidence\": \"Germline nonsense mutant zebrafish with behavioral analysis, qPCR, and quantitative proteomics\",\n      \"pmids\": [\"38908344\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Proteomic changes may be secondary to chronic seizure-like activity rather than direct α1 loss\", \"Mammalian validation of compensatory subunit changes needed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: the structural basis for why specific residue substitutions produce gain- versus loss-of-function; whether distinct mutation mechanisms (gating vs. trafficking vs. NMD) predict clinical severity or drug responsiveness; and whether pharmacological rescue strategies effective in heterologous cells (e.g., verapamil) translate to in vivo therapeutic benefit.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No high-resolution structure of disease-mutant α1-containing GABA-A receptors\", \"No genotype-stratified therapeutic trials\", \"Mechanism of verapamil rescue at the channel level undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [0, 2, 4, 7]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [5, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 4, 9]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1, 3, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [0, 2, 3, 4, 6, 7]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [1, 3, 9]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [0, 2, 6]}\n    ],\n    \"complexes\": [\n      \"GABA-A receptor (α1β2γ2 heteropentamer)\"\n    ],\n    \"partners\": [\n      \"GABRB2\",\n      \"GABRG2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}